Читаем Хочу быть здоровой. Женщинам о норме, болях, заболеваниях, лечении, гормонах и многом другом полностью

1) Sacco, Simona et al. “Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC).” The journal of headache and pain vol. 18,1 108. 30 Oct. 2017, doi:10.1186/s10194-017–0815-1

2) Ornello, R., De Matteis, E., Di Felice, C., Caponnetto, V., Pistoia, F., & Sacco, S. (2021). “Acute and Preventive Management of Migraine during Menstruation and Menopause.” Journal of clinical medicine, 10(11), 2263. https://doi.org/10.3390/jcm10112263

3) Allais, G. et al. “Menstrual migraine: a review of current and developing pharmacotherapies for women.” Expert opinion on pharmacotherapy vol. 19,2 (2018): 123–136. doi:10.1080/14656566.2017.1414182

4) Facchinetti, F. et al. “Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium.” Headache vol. 31,5 (1991): 298–301. doi:10.1111/j.1526–4610.1991.hed3105298.x

5) Медицинские критерии приемлемости для использования методов контрацепции ВОЗ. 5-е издание. 2015. URL: https://iris.who.int/bitstream/handle/10665/326788/9789289052689-rus.pdf?sequence=3&isAllowed=y

5. РОСТ ВОЛОС

1) Screening and Management of the Hyperandrogenic Adolescent: ACOG Committee Opinion, Number 789. URL: https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2019/10/screening-and-management-of-the-hyperandrogenic-adolescent

2) Barrionuevo, Patricia et al. “Treatment Options for Hirsutism: A Systematic Review and Network Meta-Analysis.” The Journal of clinical endocrinology and metabolism vol. 103,4 (2018): 1258–1264. doi:10.1210/jc.2017–02052

6. МЕНСТРУАЛЬНЫЙ ЦИКЛ

1) Munro, Malcolm G. et al. “The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions.” International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics vol. 143,3 (2018): 393–408. doi:10.1002/ijgo.12666

2) Jones S. L., Campbell B., Hart T. “Laboratory tests commonly used in complementary and alternative medicine: a review of the evidence.” Annals of Clinical Biochemistry. 2019; 56(3):310–325. doi:10.1177/0004563218824622

7. ГОРМОНЫ

1) Hormone Therapy in Postmenopausal Persons: Primary Prevention of Chronic Conditions // The U.S. Preventive Services Task Force. November 01, 2022. URL: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/menopausal-hormone-therapy-preventive-medication#fullrecommendationstart

2) The 2022 hormone therapy position statement of The North American Menopause Society // The Menopouse Society. 2022. URL: https://menopause.org/professional-resources/position-statements

3) Hamoda, Haitham et al. “The British Menopause Society & Women’s Health Concern 2020 recommendations on hormone replacement therapy in menopausal women.” Post reproductive health vol. 26,4 (2020): 181–209. doi:10.1177/2053369120957514

4) Hamoda, Haitham et al. “BMS, IMS, EMAS, RCOG and AMS joint statement on menopausal hormone therapy and breast cancer risk in response to EMA Pharmacovigilance Risk Assessment Committee recommendations in May 2020.” Post reproductive health vol. 27,1 (2021): 49–55. doi:10.1177/2053369120983154

5) Boardman, Henry M. P. et al. “Hormone therapy for preventing cardiovascular disease in post-menopausal women.” The Cochrane database of systematic reviews vol. 2015,3 CD002229. 10 Mar. 2015, doi:10.1002/14651858.CD002229.pub4

6) Collaborative Group on Hormonal Factors in Breast Cancer. “Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence.” Lancet (London, England) vol. 394,10204 (2019): 1159–1168. doi:10.1016/S0140–6736(19)31709-X

7) Chlebowski, Rowan T. et al. “Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women’s Health Initiative Randomized Clinical Trials.” JAMA vol. 324,4 (2020): 369–380. doi:10.1001/jama.2020.9482

8) Cordina-Duverger, Emilie et al. “Risk of breast cancer by type of menopausal hormone therapy: a case-control study among post-menopausal women in France.” PloS one vol. 8,11 e78016. 1 Nov. 2013, doi:10.1371/journal.pone.0078016

8. КРОВОТЕЧЕНИЕ